Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Alkan

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
JCO Oncology Practice|February 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional StudyEnes Erul, Vilma Pacheco-Barcia, Ali Alkan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a patient with primary mucinous testicular adenocarcinoma as a rare case with adjuvant and metastatic sequential treatmentsOzgur Tanriverdi, Mehmet Levent Tarimer, Ceren Deniz Pak, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 25, 2020
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case reportOzgur Tanriverdi, Mehmet L Tarimer, Ceren D Pak, et al.
BMC Cancer|March 12, 2026
Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer)Taliha Guclu, Ozgur Tanriverdi, Ismail Bayrakci, et al.
Cancer Investigation|January 13, 2026
Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017-2025)Bilgin Demir, Özgür Tanrıverdi, Taliha Güçlü, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAli Alkan, Arzu Yaşar, Ebru Karcı, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a glottic squamous cell carcinoma with cutaneous metastasisAli Alkan, Deniz Kayış, Serkan Yaşar Çelik, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in TürkiyeOzgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2017
Vaccination in oncology practice and predictorsAli Alkan, Ebru Karcı, Arzu Yaşar, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
JCO Oncology Practice|February 25, 2026
Imposter Syndrome, Burnout, and Maladaptive Perfectionism Among Oncology Professionals: A Global Cross-Sectional StudyEnes Erul, Vilma Pacheco-Barcia, Ali Alkan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a patient with primary mucinous testicular adenocarcinoma as a rare case with adjuvant and metastatic sequential treatmentsOzgur Tanriverdi, Mehmet Levent Tarimer, Ceren Deniz Pak, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 25, 2020
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case reportOzgur Tanriverdi, Mehmet L Tarimer, Ceren D Pak, et al.
BMC Cancer|March 12, 2026
Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer : (Ki67 and inflammation in triple-negative breast cancer)Taliha Guclu, Ozgur Tanriverdi, Ismail Bayrakci, et al.
Cancer Investigation|January 13, 2026
Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017-2025)Bilgin Demir, Özgür Tanrıverdi, Taliha Güçlü, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 14, 2016
Severe drug interactions and potentially inappropriate medication usage in elderly cancer patientsAli Alkan, Arzu Yaşar, Ebru Karcı, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2020
Management of a glottic squamous cell carcinoma with cutaneous metastasisAli Alkan, Deniz Kayış, Serkan Yaşar Çelik, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in TürkiyeOzgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 24, 2017
Vaccination in oncology practice and predictorsAli Alkan, Ebru Karcı, Arzu Yaşar, et al.
Oncology Research and Treatment|January 13, 2026
Proliferation-Guided Risk Stratification in HER2-Low vs. HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective AnalysisSait Kitapli, Özgür Tanriverdi, İsmail Bayrakci, et al.
Pageof 12